Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


NIOSH Radiation Dose Reconstruction Program


Section Navigation
			
			CDC Home








alert icon
            Cybersecurity Modernization Initiative
                We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
								

				Argonne National Laboratory – West						Print
																Related Pages
										On This Page
			Special Exposure CohortAdvisory Board Work GroupTechnical DocumentsAdvisory Board and NIOSH DiscussionsProgram Evaluation Plans and Reports (PEPs and PERs)Public CommentsDocument Archive
		
(Site Profile/Docket Number 038)
Location: Scoville, Idaho
Special Exposure Cohort Petition Information
The Special Exposure Cohort (SEC) is a unique category of employees established by the Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 “specified cancers,” and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.
Open/Active SEC Petitions
To date, there are no open/active SEC petitions from Argonne National Laboratory-West.
Class(es) Added to the SEC
All employees of the Department of Energy, its predecessor agencies, and their contractors and subcontractors who worked at the Argonne National Laboratory-West during the time period from April 10, 1951, through December 31, 1957, for a number of work days aggregating at least 250 work days, occurring either solely under this employment, or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort.
**Note:**This class was established from Petition 224Petitions Qualified for Evaluation
Below is a list of the petitions that qualified for evaluation. Select a petition on the list to view the table for that particular petition.
Petition 224 (April 10, 1951 to December 31, 1979)
	Petition 224
Steps in Petition Process:
Petition Details:Date Received
December 4, 2014Date Qualified for Evaluation
March 13, 2015Summary of Information in Petition
**Location: Scoville, Idaho**
**Job Titles and/or Job Duties:** All workers who worked in any location of the Argonne National Laboratory – West.
**Period of Employment:** April 10, 1951 through December 31, 1979.
**Note:** The information above is what qualified for evaluation. During our evaluation of whether dose reconstructions can adequately be completed for the above job titles and period of employment, information may cause NIOSH to change some the dates or job titles/duties. Therefore, as this petition proceeds through the SEC petition process and if an SEC class is proposed, the proposed class may not exactly match the above information.Copy of the Petition Received
December 4, 2014 [761 KB (8 pages)]
(January 1, 1949 to December 31, 2005)Federal Register Notice Announcing that an Argonne National Laboratory – West SEC Petition has met the Minimum Qualifications for Review and Evaluation
March 25, 2015 [57 KB (1 page)]
(April 10, 1951 through December 31, 1979)SEC Petition Evaluation Report
February 18, 2016 [9 MB (260 pages)]
(April 10, 1951 through December 31, 1979)Evaluation Report Sent to the Advisory Board
February 24, 2016
(April 10, 1951 through December 31, 1979)Petition Discussed by the Advisory Board
The petition was discussed on March 23, 2016, during the Advisory Board’s regular meeting.
**Note:** Agendas and transcripts for Board meetings will be posted on the Advisory Board and Public Meetings page as soon as they become available.Advisory Board Recommendation on SEC Petition
May 2, 2016 [71 MB (2 pages)]
(April 10, 1951 through December 31, 1957)HHS Letters to Congress Regarding the SEC Petition
June 3, 2016 [127 KB (14 pages)]
(April 10, 1951 through December 31, 1957)HHS Designation/Determination of Additional Members to the SEC
**Designation:**
June 3, 2016 [159 KB (5 pages)]
(April 10, 1951 through December 31, 1957)
**Note:** A “designation” means that HHS is recommending a class be added to the SEC. A “determination” means that HHS is recommending a class **not** be added to the SEC.Federal Register Notice: Designation/Determination Regarding a Class of Employees for Addition to the Special Exposure Cohort
**Designation:**
June 17, 2016 [56 KB (1 page)
(April 10, 1951 through December 31, 1957)
**Note:** A “designation” will be published if there is a recommendation to add a class to the SEC. A “determination” will be published if there is a recommendation not to add a class to the SEC.Effective Date for the SEC Class
July 3, 2016
(April 10, 1951 through December 31, 1957)
**Note:** This only applies if the class is added to the SEC.Federal Register Notice: Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort
July 19, 2016 [78 KB (2 pages)]
(April 10, 1951 through December 31, 1957)
**Note:** This only applies if the class is added to the SEC.Letter to DOL Regarding the Addition of a New Class of Employees to the SEC
July 5, 2016 [71 KB (1 page)]
(April 10, 1951 through December 31, 1957)
**Note:** This only applies if the class is added to the SEC.
SEC Petitions Not Qualifying for Evaluation
In addition to the petition listed above, one petition was received but did not qualify for evaluation.
Advisory Board Work Group on Argonne National Laboratory-West/Idaho National Laboratory
This Work Group is responsible for a review of the Argonne National Laboratory-West and Idaho National Laboratory Site Profiles (as revised) and a review of the Site Profiles by the Board’s contractor (SC&A). The Work Group shall consider issues identified by SC&A concerning the Site Profiles and shall assist NIOSH and SC&A in the resolution of such issues. The Work Group may recommend to the Board changes in the Site Profiles as appropriate. The Work Group is also responsible for a review of SEC petitions from Argonne National Laboratory-West and Idaho National Laboratory petitioners, the resultant SEC Petition Evaluations from NIOSH, and any SC&A reviews of the SEC Petitions and NIOSH Petition Evaluations. The Work Group shall assist NIOSH and SC&A in the resolution of issues concerning the petitions and should strive to develop a recommendation to the Board on whether a class should be added to the SEC. Meeting information (including agendas and transcripts) for this Work Group can be found on either the individual site page for Idaho National Laboratory, Argonne National Laboratory-West, or the Advisory Board and Public Meetings page.
**Work Group Members:**
Genevieve S. Roessler, Ph.D. (Chair)
Henry A. Anderson, M.D.
Josie Beach
Meeting Information:
**July 16, 2020**Teleconference Meeting of the Advisory Board’s Work Group on Argonne National Laboratory-West/Idaho National Laboratory
Time/Location:
11:00 a.m. (Eastern Time)
                    Meeting Type: Teleconference; Public, No Comment Period
Teleconference: +1-866-659-0537
                    Participant Code: 9933701
Pre-Decisional Document Policy
Available Meeting Items:
Agenda [22 KB (1 page)]
Transcript [450 KB (114 pages)]Presentations:
NIOSH/DCAS: Review of NIOSH Response to SC&A Draft Review of NIOSH’s Evaluation Report for Petition SEC-00219, Idaho National Laboratory: Burial Ground, 1952–1970 [662 KB (36 pages)]
SC&A: Review of NIOSH Response to SC&A Draft Review of NIOSH’s Evaluation Report for Petition SEC-00219, Idaho National Laboratory: Burial Ground, 1952–1970 [1.5 MB (18 pages)]
NIOSH/DCAS: ORAUT-RPRT-0099 – Evaluation of EBR-II and BORAX-IV for ORAUT-OTIB-0054 Applicability [996 KB (32 pages)]
SC&A: INL/ANL-W Site Profile BRS Status [256 KB (6 pages)]
SC&A: Reactor Characterization Studies [207 KB (5 pages)]Discussion/Background Papers:
SC&A Memo: 83.14 Verification and Validation of Temporary Badges at the Chemical Processing Plant (1975–1980) [230 KB (11 pages)]
                        June 25, 2020
SC&A Draft: Review of NIOSH “Response to SC&A-TR-2017-007, Draft Review of NIOSH’s Evaluation Report for Petition SEC-00219, Idaho National Laboratory: Burial Ground, 1952-1970” [1.3 MB (31 pages)]
                        May 20, 2020
NIOSH/ORAU: Evaluation of EBR-II and BORAX-IV for ORAUT-OTIB-0054 Applicability [480 KB (30 pages)]
                        Document No. ORAUT-RPRT-0099, Rev 00
                        May 8, 2020
NIOSH/ORAU: Response to SCA-TR-2017-007, Draft Review of NIOSH’s Evaluation Report for Petition SEC-00219, Idaho National Laboratory: Burial Ground, 1952-1970 [8 MB (103 pages)]
                        January 13, 2020
**March 25, 2019**Teleconference Meeting of the Advisory Board’s Work Group on Argonne National Laboratory-West/Idaho National Laboratory
Time/Location:
9:00 a.m. (Eastern Time)
                    Meeting Type: Teleconference; Public, No Comment Period
Teleconference: +1-866-659-0537
                    Participant Code: 9933701
Pre-Decisional Document Policy
Agenda [26 KB (1 page)]
Transcript [344 KB (73 pages)]Presentations:
SC&A: SEC-00219: Idaho National Laboratory – Chemical Processing Plant – Verification and Validation of Class Definition (1963 – 1970) [198 KB (15 pages)]
SC&A: SEC-00238: Idaho National Laboratory – Chemical Processing Plant – Verification and Validation of Class Definition (1975-1980) [125 KB (12 pages)]
NIOSH/DCAS: Evaluation of INL Burial Ground/RWMC Post-1970 (SEC00219) [4 MB (36 pages)]Discussion/Background Papers:
SC&A Memo: Verification and Validation Proposal for the SEC-00238 83.14 Period at the Chemical Processing Plant (1975–1980) [438 KB (14 pages)]
                        February 25, 2019
SC&A Draft: Verification and Validation of Temporary Badges at the Chemical Processing Plant (1963-1970), Rev. 0 [1.1 MB (21 pages)]
                        February 25, 2019
**August 9, 2018**
            Teleconference Meeting of the Advisory Board’s Work Group on Argonne National Laboratory-West/Idaho National Laboratory
Time/Location:
1:00 p.m. Eastern Time (ET)
                Meeting Type: Teleconference; Public, No Comment Period
Teleconference: +1-866-659-0537
                Participant Code: 9933701
Pre-Decisional Document Policy
Available Meeting Items:
Agenda [54 KB (1 page)]
Transcript [371 KB (79 pages)]Presentations:
NIOSH/DCAS: INL Temporary Badge Validation and Verification – Discussion Points [363 KB (11 pages)]Discussion/Background Papers:
SC&A Memo: Interim Status of Verification and Validation Activities for CPP (1963–1970) [402 KB (9 pages)]
                    July 26, 2018
SC&A Draft: Evaluation of Uranium Dose Reconstruction Methods at CPP (1953–1962) [381 KB (18 pages)]
                    July 25, 2018
NIOSH/ORAU: Response to SCA-TR-2017-SEC008, “Draft Review of Internal Alpha Exposure Potential at CPP Prior to 1963” [763 KB (36 pages)]
                    April 18, 2018
SC&A Draft: Review of External Dosimetry Records for the Chemical Processing Plant 83.14 SEC Period (1975–1980) [439 KB (27 pages)]
                    February 20, 2018
**August 14, 2017**
            Teleconference Meeting of the Advisory Board’s Work Group on Argonne National Laboratory-West/Idaho National Laboratory
Time/Location:
10:30 a.m. Eastern Time (ET)
                Meeting Type: Teleconference; Public, No Comment Period
Teleconference: +1-866-659-0537
                Participant Code: 9933701
Pre-Decisional Document Policy
Available Meeting Items:
Agenda [30 KB (1 page)]
Transcript [398 KB (101 pages)]Discussion/Background Papers:
SC&A Memo: Update on Validation and Verification of INL CPP Temporary Badge Database – Expansion of Claimant Pool (1963–1970) [59 KB (3 pages)]
                    August 3, 2017
Idaho National Laboratory Special Exposure Cohort (SEC) Petition Evaluation Report, Petition 238 [1 MB (55 pages)]
                    July 20, 2017
SC&A Draft: Draft Review of Internal Alpha Exposure Potential at CPP Prior to 1963 [2 MB (52 pages)]
                    July 10, 2017
**May 16, 2017**
            Teleconference Meeting of the Advisory Board’s Work Group on Argonne National Laboratory-West/Idaho National Laboratory
Time/Location:
10:00 a.m. Eastern Standard Time (EST)
                Meeting Type: Teleconference; Public, No Comment Period
Teleconference: +1-866-659-0537
                Participant Code: 9933701
Pre-Decisional Document Policy
Available Meeting Items:
Agenda [49 KB (1 page)]
Transcript [564 KB (130 pages)]Presentations:
SC&A Presentation: INL/ANL-W Reactor Prioritization & Other Reactor-Related Issues [501 KB (23 pages)]Discussion/Background Papers:
SC&A Draft: Draft Review of NIOSH’s Evaluation Report for Petition SEC-00219, Idaho National Laboratory: Burial Ground, 1952-1970, Rev. 0 [2 MB (54 pages)]
                    May 1, 2017
SC&A Draft: Response to NIOSH Reactor Analysis Plan and Consolidation of All Reactor Modeling Comments, Rev. 0 [1 MB (59 pages)]
                    December 8, 2016
SC&A Memo: Verification and Validation (V&V) Plan for Temporary Badges at CPP (1963–1970), [180 KB (9 pages)]
                    September 29, 2016
NIOSH/DCAS: NIOSH Proposal for INL and ANL-W Reactor Prioritization for OTIB-0054 Evaluation [603 KB (9 pages)]
                    July 28, 2016
SC&A Draft: Evaluation of Monitoring Practices for Claimants at Argonne National Laboratory–West [1 MB (59 pages)]
                    July 8, 2016
**September 8, 2016**
                    Teleconference Meeting of the Advisory Board’s Work Group on Argonne National Laboratory-West/Idaho National Laboratory
Time/Location:
10:30 a.m. (Eastern Time)
                        Meeting Type: Teleconference; Public, No Comment Period
Teleconference: +1-866-659-0537
                        Participant Code: 9933701
Available Meeting Items:
Agenda [120 KB (1 page)]Pre-Decisional Document Policy
**August 2, 2016**
                    Meeting of the Advisory’s Board’s Argonne National Laboratory-West/Idaho National Laboratory Work Group
Time/Location:
9:00 a.m. (Eastern Time)
                        Meeting Type: Face-to-Face; Public, No Comment Period
Cincinnati Airport Marriott
                    2395 Progress Dr.
                    Hebron, KY 41048
                    Phone: 859-586-0166
                    Toll-Free: 1-877-222-7570
                    Fax: 859-586-0266
Teleconference: +1-866-659-0537
                        Participant Code: 9933701
Pre-Decisional Document Policy
Available Meeting Items:
Agenda [213 KB (2 pages)]
Transcript [609 KB (287 pages)]Discussion Papers:
SC&A Draft: Review of Special Exposure Cohort Evaluation Report for Westinghouse Electric Corp. SEC-00217, Rev. 0 [401 KB (20 pages)]
                            July 30, 2015
NIOSH/DCAS: NIOSH Proposal for INL and ANL-W Reactor Prioritization for OTIB-0054 Evaluation [603 KB (9 pages)]
                            July 28, 2016
NIOSH/DCAS: Evaluation of 32 Additional INL Claims for the SEC00219 Proposed Class Definition [352 KB (5 pages)]
                            July 20, 2016
NIOSH/DCAS: Completeness of INL Chemical Processing Plant (CPP) Badges for SEC Class Definition [938 KB (9 pages)]
                            July 19, 2016
SC&A Draft: Integrated Status Report of Site Profile and SEC Issues Related to INL and ANL-W [690 KB (48 pages)]
                            Contract No. 211-2014-58081 SCA-TR-2016-SEC011, Revision 0
                            July 15, 2016
SC&A Memo: SC&A’s July 2016 Progress Report: ANL-W Area Monitoring Data Review [67 KB (5 pages)]
                            July 14, 2016
SC&A Memo: Progress Report: SC&A’s Evaluation of Sr-90/Cs-137, FAP/Cs-137, and Actinides/Cs-137 Ratios Using ANL-W Measured Values in Relationship to Assigning Intakes [288 KB (15 pages)]
                            July 14, 2016
SC&A Memo: Progress Report, ANL-W SEC-00224 Review, Strategy of Using the 10% Maximum Permissible Concentration Rule for Performing Dose Reconstruction [64 KB (4 pages)]
                            July 14, 2016
SC&A Draft: Argonne National Laboratory-West SEC-00224 Reactor Prioritization for Evaluation of ORAUT-OTIB-0054 Applicability [224 KB (26 pages)]
                            Contract No. 211-2014-58081 SCA-TR-2016-SEC010, Revision 0
                            July 13, 2016
SC&A Draft: Review of Petition Evaluation Report for SEC-00224, Argonne National Laboratory-West Regarding the Use of General Area Air Sampling for Internal Dose Assessment [15.4 MB (43 pages)]
                            Contract No. 211-2014-58081 SCA-TR-2016-SEC009, Revision 0
                            July 13, 2016
SC&A Draft: Evaluation of Monitoring Practices for Claimants at Argonne National Laboratory–West [1 MB (59 pages)]
                            July 8, 2016
SC&A Draft: Evaluation of New Claims Filed Since the Summer of 2015 for Idaho National Laboratory – Executive Summary [98 KB (10 pages)
                            Contract No. 211-2014-58081 SCA-TR-2016-SEC004-Summary, Revision 0
                            July 6, 2016
SC&A Memo: Status of OTIBs Identified in Section 4.2 of Argonne National Laboratory–West (ANL-W) Special Exposure Cohort (SEC) Evaluation Report (ER) [81 KB (7 pages)]
                            June 28, 2016
SC&A Draft: SC&A’s Evaluation of CS-137/SR-90 Values and Actinides Using INL Waste Reports in Relationship to Assigning Intakes, Rev. 0 [520 KB (31 pages)
                            Contract No. 211-2014-58081 SCA-TR-2016-SEC007, Revision 0
                            June 24, 2016
SC&A Draft: INL SEC-00219 Reactor Prioritization for Evaluation of ORAUT-OTIB-0054 Applicability, Rev. 1 [435 KB (44 pages)
                            Contract No. 211-2014-58081 SCA-TR-2016-SEC002, Revision 1
                            June 10, 2016Pre-Decisional Document Policy
Please note that as part of the procedures and processes of the Advisory Board’s Work Groups, several kinds of pre-decisional documents may be developed. These pre-decisional documents, such as white papers, matrices, working drafts, etc., are distributed among Work Group members as research and background tools to facilitate discussion and deliberation. Although discussion during a public meeting may cover pre-decisional documents, these documents often are not further revised or finalized, and thus do not reflect the final determination or evaluation of the Advisory Board and its Work Groups. Additionally, some pre-decisional documents not otherwise posted on the website may contain sensitive information, which would require an interested party to obtain such documents by filing a Freedom of Information Act (FOIA) request with the CDC/ATSDR FOIA office at foiarequests@cdc.gov.
Technical Documents
If the energy employee’s personal radiation information is incomplete, NIOSH will use other sources to estimate the radiation dose. This may involve using technical documents called Site Profiles, Technical Basis Documents, and Technical Information Bulletins.
Site Profile
Introduction [72 KB (9 pages)]
                    Revised March 12, 2010
**Revision Includes:** Revised to combine the Idaho National Laboratory and Argonne National Laboratory–West Introduction sections into a single document. Updated NIOSH required language. Incorporates formal internal and NIOSH review comments.
Site Description [736 KB (86 pages)]
                    Revised August 2, 2010
**Revision Includes:** Combines Idaho National Laboratory and Argonne National Laboratory–West Site Descriptions. Incorporates formal internal and NIOSH review comments.
Occupational Medical Dose [231 KB (19 pages)]
                    Revised December 21, 2009
**Revision Includes** Revised to combine Argonne National Laboratory–West Occupational Medical Dose Technical Basis Document (ORAUT-TKBS-0026-3 Rev 01) into the Idaho National Laboratory Occupational Medical Dose Technical Basis Document. Separated X-ray doses into posterior-anterior and lateral in Tables 3-7 and 3-8. Incorporates formal internal and NIOSH review comments. Constitutes a total rewrite of the document.
Occupational Environmental Dose [2.6 MB (67 pages)]
                    Revised January 8, 2010
**Revision Includes** Revised to combine Argonne National Laboratory–West TBD into the Idaho National Laboratory TBD. Updated Intake and External Dose tables to add data from 2006 to 2008. Added 129I intake values to intake tables for all areas. Incorporates formal internal review comments. No changes were needed as a result of formal NIOSH review. Constitutes a total rewrite of the document.
Occupational Internal Dose [551 KB (63 pages)]
                    Revised March 2, 2010
**Revision Includes:** Incorporates the Argonne National Laboratory–West site. In order to resolve several issues identified in an independent audit of this TBD and other issues identified by Oak Ridge Associated Universities, the approaches for assessing the Idaho National Laboratory bioassay data have been completely revised. The potential lung absorption types to be considered have also been expanded for several radionuclides. These changes generally result in lower organ doses. However, for specific scenarios they can result in higher doses to certain metabolic organs such as the thyroid. In addition, this revision fully incorporates the Argonne National Laboratory – West back into this TBD and eliminates the ANL-W Occupational Internal Dose TBD. Incorporates formal internal and NIOSH review comments. Constitutes a total rewrite of the document.
Occupational External Dose [1.3 MB (58 pages)]
                    Revised April 19, 2011
**Revision Includes:** Incorporates Argonne National Laboratory–West – Occupational External Dose Technical Basis Document (ORAUT-TKBS-0026-6 Rev 01) into the Idaho National Laboratory Occupational External Dosimetry Technical Basis Document. Incorporates formal internal and NIOSH review comments. Removed the Site Expert line from page 1 since the former Site Expert served no role in this revision. Updated Section 6.8 to reflect that in all cases where the former site expert’s information or prior studies or writings are included or relied on by the new Document Owner, those materials are fully attributed to the source in accordance with the “NIOSH Policy Statement: Management of Conflict or Bias in the Radiation Dose Reconstruction Program.” Constitutes a total rewrite of the document.Advisory Board and NIOSH Discussions on Argonne National Laboratory – West
The Argonne National Laboratory – West discussion papers listed below are working documents prepared by NIOSH or its contractor for use in discussions with the Advisory Board on Radiation and Worker Health or its Working Groups or Subcommittees. Draft, preliminary, interim, and white paper documents are not final NIOSH or Advisory Board (or their technical support and review contractors) positions unless specifically marked as such. These documents represent preliminary positions taken on technical issues prepared by NIOSH or its contractor. The discussion papers have been reviewed to identify and redact any information that is protected by the Privacy Act 5 USC §552a and have been cleared for distribution.
NIOSH/DCAS Presentation: Argonne National Laboratory West SEC-00224 Update [602 KB (22 pages)]
                    Presentation at the August 17-18, 2022, Meeting of the Advisory Board on Radiation and Worker Health
NIOSH/ORAU: ORAUT-RPRT-0089, Evaluation of Issues in the Use of General Area Air Sampling for Argonne National Laboratory-West Internal Dose Assessment, Revision 00 [4 MB (72 pages)]
                    April 19, 2022
SC&A Draft: SC&A’s Evaluation of ORAUT-OTIB-0049, Revision 02, “Estimating Doses for Plutonium Strongly Retained in the Lung” [1.3 MB (39 pages)]
                    Contract No. 75D30119C04183
                    Document No. SCA-TR-2021-PR049, Revision 0
                    October 7, 2021
SC&A: Review of ORAUT-RPRT-0099 Evaluation of EBR-II and BORAX-IV for ORAUT-OTIB-0054 Applicability [132 KB (17 pages)]
                    Contract No. 75D30119C04183
                    Document No. SCA-TR-2021-SEC001, Revision 0
                    January 15, 2021
Advisory Board: SEC-00238 – Verification and Validation of Temporary Badges at the Chemical Processing Plant (1975–1980) [310 KB (8 pages)]
                    Presentation at the August 26-27, 2020, Meeting of the Advisory Board on Radiation and Worker Health
NIOSH/DCAS: Review of NIOSH Response to SC&A Draft Review of NIOSH’s Evaluation Report for Petition SEC-00219, Idaho National Laboratory: Burial Ground, 1952–1970 [662 KB (36 pages)]
                    Presentation at the July 16, 2020, Teleconference Meeting of the Advisory Board’s Work Group on Argonne National Laboratory-West/Idaho National Laboratory
NIOSH/DCAS: ORAUT-RPRT-0099 – Evaluation of EBR-II and BORAX-IV for ORAUT-OTIB-0054 Applicability [996 KB (32 pages)]
                    Presentation at the July 16, 2020, Teleconference Meeting of the Advisory Board’s Work Group on Argonne National Laboratory-West/Idaho National Laboratory
SC&A: INL/ANL-W Site Profile BRS Status [256 KB (6 pages)]
                    Presentation at the July 16, 2020, Teleconference Meeting of the Advisory Board’s Work Group on Argonne National Laboratory-West/Idaho National Laboratory
SC&A: Reactor Characterization Studies [207 KB (5 pages)]
                    Presentation at the July 16, 2020, Teleconference Meeting of the Advisory Board’s Work Group on Argonne National Laboratory-West/Idaho National Laboratory
SC&A: Review of NIOSH Response to SC&A Draft Review of NIOSH’s Evaluation Report for Petition SEC-00219, Idaho National Laboratory: Burial Ground, 1952–1970 [1.5 MB (18 pages)]
                    Presentation at the July 16, 2020, Teleconference Meeting of the Advisory Board’s Work Group on Argonne National Laboratory-West/Idaho National Laboratory
SC&A Memo: 83.14 Verification and Validation of Temporary Badges at the Chemical Processing Plant (1975–1980) [230 KB (11 pages)]
                    June 25, 2020
SC&A Draft: Review of NIOSH “Response to SC&A-TR-2017-007, Draft Review of NIOSH’s Evaluation Report for Petition SEC-00219, Idaho National Laboratory: Burial Ground, 1952-1970” [1.3 MB (31 pages)]
                    May 20, 2020
NIOSH/ORAU: Evaluation of EBR-II and BORAX-IV for ORAUT-OTIB-0054 Applicability [480 KB (30 pages)]
                    Document No. ORAUT-RPRT-0099, Rev 00
                    May 8, 2020
SC&A Memo: Interim Status of Verification and Validation Activities for CPP (1963–1970) [389 KB (9 pages)]
                    July 26, 2018
SC&A Draft: Evaluation of Uranium Dose Reconstruction Methods at CPP (1953–1962) [381 KB (18 pages)]
                    Contract No. 211-2014-58081
                    SCA-TR-2018-SEC003, Revision 0
                    July 25, 2018
SC&A Memo: Update on Validation and Verification of INL CPP Temporary Badge Database – Expansion of Claimant Pool (1963–1970) [59 KB (3 pages)]
                    August 3, 2017
SC&A Presentation: INL/ANL-W Reactor Prioritization & Other Reactor-Related Issues [501 KB (23 pages)]
                    (Presentation from the May 16, 2017, Teleconference Meeting of the Advisory Board’s Work Group on Argonne National Laboratory-West/Idaho National Laboratory)
SC&A Draft: SC&A’s Evaluation of Cs-137/Sr-90, Fission and Activation Product, and Actinide Values Using ANL-W Monthly and Annual Waste Reports in Relationship to Assigning Intakes [457 KB (26 pages)]
                    Contract No. 211-2014-58081 SCA-TR-2017-SEC002, Revision 0
                    January 20, 2017
SC&A Draft: SC&A’s Evaluation of Cs-137/Sr-90, Fission and Activation Product, and Actinide Values Using INL Monthly and Annual Waste Reports in Relationship to Assigning Intakes [5.8 MB (39 pages)]
                    Contract No. 211-2014-58081 SCA-TR-2017-SEC001, Revision 0
                    January 11, 2017
NIOSH/DCAS: NIOSH Proposal for INL and ANL-W Reactor Prioritization for OTIB-0054 Evaluation [603 KB (9 pages)]
                    July 28, 2016
SC&A Draft: Response to NIOSH Reactor Analysis Plan and Consolidation of All Reactor Modeling Comments [1 MB (59 pages)]
                    Contract No. 211-2014-58081 SCA-TR-2016-SEC012, Revision 0
                    December 8, 2016
SC&A Presentation: SC&A Status Update: SEC-00219 INL and SEC-00224 ANL-W [479 KB (58 pages)]
                    Presented at the August 9-10, 2016, Meeting of the Advisory Board on Radiation and Worker Health
SC&A Draft: Integrated Status Report of Site Profile and SEC Issues Related to INL and ANL-W [690 KB (48 pages)]
                    Contract No. 211-2014-58081 SCA-TR-2016-SEC011, Revision 0
                    July 15, 2016
SC&A Memo: SC&A’s July 2016 Progress Report: ANL-W Area Monitoring Data Review [67 KB (5 pages)]
                    July 14, 2016
SC&A Memo: Progress Report: SC&A’s Evaluation of Sr-90/Cs-137, FAP/Cs-137, and Actinides/Cs-137 Ratios Using ANL-W Measured Values in Relationship to Assigning Intakes [288 KB (15 pages)]
                    July 14, 2016
SC&A Memo: Progress Report, ANL-W SEC-00224 Review, Strategy of Using the 10% Maximum Permissible Concentration Rule for Performing Dose Reconstruction [64 KB (4 pages)]
                    July 14, 2016
SC&A Draft: Argonne National Laboratory-West SEC-00224 Reactor Prioritization for Evaluation of ORAUT-OTIB-0054 Applicability [224 KB (26 pages)]
                    Contract No. 211-2014-58081 SCA-TR-2016-SEC010, Revision 0
                    July 13, 2016
SC&A Draft: INL SEC-009 Review of Petition Evaluation Report for SEC-00224, Argonne National Laboratory-West Regarding the Use of General Area Air Sampling for Internal Dose Assessment, Rev. 0 [15.4 MB (43 pages)
                    Contract No. 211-2014-58081 SCA-TR-2016-SEC009, Revision 0
                    July 13, 2016
SC&A Draft: Evaluation of Monitoring Practices for Claimants at Argonne National Laboratory–West [1 MB (59 pages)]
                    Contract No. 211-2014-58081 SCA-TR-2016-SEC008, Revision 0
                    July 8, 2016
SC&A Memo: Status of OTIBs Identified in Section 4.2 of Argonne National Laboratory–West (ANL-W) Special Exposure Cohort (SEC) Evaluation Report (ER) [81 KB (7 pages)]
                    June 28, 2016
SC&A Draft: SC&A’s Evaluation of CS-137/SR-90 Values and Actinides Using INL Waste Reports in Relationship to Assigning Intakes, Rev. 0 [520 KB (31 pages)
                    Contract No. 211-2014-58081 SCA-TR-2016-SEC007, Revision 0
                    June 24, 2016
SC&A Draft: INL SEC-00219 Reactor Prioritization for Evaluation of ORAUT-OTIB-0054 Applicability, Rev. 1 [435 KB (44 pages)
                    Contract No. 211-2014-58081 SCA-TR-2016-SEC002, Revision 1
                    June 10, 2016
NIOSH/DCAS Presentation: Argonne National Laboratory-West Special Exposure Cohort Petition Evaluation Report, Petition 224 [1 MB (43 pages)]
                    Presented at the March 23-24, 2016, Meeting of the Advisory Board on Radiation and Worker Health
SC&A Draft: A Review of NIOSH’S “Program Evaluation Report: Evaluation of Incomplete Internal Dosimetry Records from Idaho, Argonne – East and Argonne – West National Laboratories” [436 KB (49 pages)]
                    Contract No. 200-2009-28555 SCA-TR-PR2012-0017, Rev. 0
                    May 15, 2012Program Evaluation Plans (PEPs) and Program Evaluation Reports (PERs)
NIOSH is committed to applying the best available science in dose reconstructions. In keeping with this commitment, completed cases with probabilities of causation less than 50% are reviewed as relevant new information becomes available. The results of these reviews are described in a Program Evaluation Report (PER). The PER details the effect, if any, of the new information on the completed dose reconstruction. If it appears that the new information may result in an increase in dose for a completed dose reconstruction with a probability of causation of less than 50%, NIOSH is committed to working with the Department of Labor to reopen and rework the dose reconstruction, as appropriate. A Program Evaluation Plan (PEP) describes plans for evaluating specific program details or issues.
Program Evaluation Plans
OCAS-PEP-0017 Rev-00: Evaluation of Incomplete Internal Dosimetry Records from Idaho, Argonne – West and Argonne – West National Laboratories [17 KB (3 pages)]March 21, 2007
**About this Document:** In April/May 2006, while reviewing dose reconstructions (DR) for an Idaho National Laboratory (INL) case and an Argonne National Laboratory – West (ANL-E) case, a particular notation (“no recordable dose”) in the INL dosimetry response, as well as a similar notation (“no internal dose”) in the ANL-E dosimetry response, was questioned. Both the INL and ANL-E points of contact (POC) were contacted and asked if this notation meant that the energy employee (EE) was not monitored. The INL POC responded that this notation meant that this particular EE may have been monitored but no internal dose was assigned. The ANL-E POC provided information that the EE had internal dose records for most years of his employment. [Although Argonne National Laboratory – West (ANL-W) requests are sent through the Chicago Operations Office, the dosimetry records are provided by INL.]In May/June 2006, it was determined that INL/ANL-W/ANL-E did not consistently include internal dose data in all of their individual dosimetry responses and that additional requests were needed for submitted cases with a POC less than 50%. For a particular EE, INL/ANL-W/ANL-E either provided all or none of the EE’s internal dosimetry records. A good indicator that there may be internal dosimetry data is that the OCAS-INT-004 (check-box form) may have a hand-written note next to the internal dosimetry status section that says – “no internal dose” or no recordable dose.Program Evaluation Reports
OCAS-PER-017 Rev-00: Program Evaluation Report: Evaluation of Incomplete Internal Dosimetry Records from Idaho, Argonne – West and Argonne – West National Laboratories [21 KB (3 pages)]
                    September 11, 2007
**About this Document:** New document to determine which previously completed claims require revisions as a result of new dosimetry data at INL, ANL-E, and ANL-W.
**Summary:** Additional requests were sent in August/September 2006. By April of 2007 a response was received for each of the request. These requests resulted in receiving internal dose data for 83 claims, 62 from INL, 14 from ANL-W, 6 from ANL-E and one with additional records from both INL and ANL-W.Some of these claims have already been returned to NIOSH for new dose reconstruction for various reasons. The new dose reconstructions will consider the new data received. NIOSH is requesting the remaining claims be returned for a new dose reconstruction. This consists of 68 individual claims. A list of these claims will be forwarded to the Department of Labor. A new dose reconstruction will be completed for each of the claims using the new data.
SC&A Draft: A Review of NIOSH’S “Program Evaluation Report: Evaluation of Incomplete Internal Dosimetry Records from Idaho, Argonne – West and Argonne – West National Laboratories” [436 KB (49 pages)]
                            Contract No. 200-2009-28555 SCA-TR-PR2012-0017, Rev. 0
                            May 15, 2012
OCAS-PER-0023 Rev-00: Argonne National Lab-West TBD Revision [15 KB (1 page)]
                    September 20, 2007
**About this Document:** New document to determine which previously completed claims require evaluation for the effect of revising the ANL-W TBD.
**Summary:** There were 22 ANL-W completed with a probability of causation below 50% prior to the change in default frequency. NIOSH will review the records of each claim to determine if an x-ray frequency less than annually was used to complete the dose reconstruction for claims in which no medical records were received from DOE. NIOSH will provide DOL with the list of 22 claims as well as a determination on each claim as to whether a new dose estimate is required.Public Comments on Argonne National Laboratory – West Documents
How to Submit Comments
Comments on Argonne National Laboratory – West Documents can be submitted to the NIOSH Docket Officer electronically by email at nioshdocket@cdc.gov or printed comments can be mailed to: NIOSH Docket Office Robert A. Taft Laboratories, MS-C34 1090 Tusculum Avenue Cincinnati, OH 45226 Please include the Site Profile/Docket Number (038) on all comments.
Comments Received
At this time, no public comments have been submitted.
Document Archive for Argonne National Laboratory – West
Site Profile: Introduction section
Revised May 11, 2007 [65 KB (9 pages)]**Revision Includes**: Attributions and Annotations included. Incorporates formal internal review comments. This revision results in no change to the assigned dose and no PER is required.
**Note**: This document was canceled. There is no longer a need to keep this information in a stand-alone document. The information contained in this Technical Basis Document has been incorporated into the Idaho National Laboratory and Argonne National Laboratory-West – Introduction Technical Basis Document (ORAUT-TKBS-0007-1 Rev 03).
Approved December 1, 2004 [35 KB (7 pages)]
Site Profile: Site Description section
Revised June 22, 2007 [434 KB (31 pages)]**Revision Includes**: Added Purpose, Scope, and Attributions and Annotations sections. Updated References and formatting. Incorporates formal internal review comments. No further changes occurred as a result of formal NIOSH review . Constitutes a total rewrite of document. This revision results in no change to the assigned dose and no PER is required.
**Note**: This document was canceled. There is no longer a need to keep this information in a stand-alone document. The information contained in this Technical Basis Document has been incorporated into the Idaho National Laboratory and Argonne National Laboratory-West – Site Description Technical Basis Document (ORAUT-TKBS-0007-2 Rev 04).
Approved September 9, 2004 [382 KB (24 pages)]
Site Profile: Occupational Medical Dose section
Revised July 30, 2007 [98 KB (12 pages)]**Revision Includes**: Added Attributions and Annotations section. Moved Appendix into document. Constitutes a total rewrite of the document. Incorporates formal internal and NIOSH review comments.
**Note**: This document was canceled. There is no longer a need to keep this information in a stand-alone document. The information contained in this Technical Basis Document has been incorporated into the Idaho National Laboratory and Argonne National Laboratory-West – Occupational Medical Dose Technical Basis Document (ORAUT-TKBS-0007-3 Rev 02).
Page Change Revision May 16, 2005 [48 KB (11 pages)]**Page Change Revision Includes:** Replaces first paragraph of section 3.2 on page 4 and the associated table specifying x-ray /age requirements. Revises Table 3A-1 on page 11 to reflect these changes.
Approved September 9, 2004 [72 KB (11 pages)]
Site Profile: Occupational Environmental Dose section
Revised June 5, 2007 [832 KB (39 pages)]**Page Change Revision Includes**: Incorporates Attribution and Annotation section. Constitutes a total rewrite of the document. Incorporates formal internal and NIOSH review comments. This revision results in no change to the assigned dose and no PER is required.
**Note**: This document was canceled. There is no longer a need to keep this information in a stand-alone document. The information contained in this Technical Basis Document has been incorporated into the Idaho National Laboratory and Argonne National Laboratory-West – Occupational Environmental Technical Basis Document (ORAUT-TKBS-0007-4 Rev 02).
Approved September 30, 2004 [956 KB (26 pages)]
Site Profile: Occupational Internal Dose section
Revised May 23, 2007 [291 KB (29 pages)]**Revision Includes**: Attributions and Annotations added. Incorporates formal internal review comments. This revision results in no change to the assigned dose and no PER is required.
**Note**: This document was canceled. There is no longer a need to keep this information in a stand-alone document. The information contained in this Technical Basis Document has been incorporated into the Idaho National Laboratory and Argonne National Laboratory-West – Occupational Internal Technical Basis Document (ORAUT-TKBS-0007-5 Rev 03).
Approved January 20, 2005 [270 KB (26 pages)]
Site Profile: Occupational External Dose section
Revised May 15, 2007 [907 KB (57 pages)]**Revision Includes**: Approved revision for biennial review. Incorporates Attributions and Annotations. Constitutes a total rewrite of the document. Incorporates formal internal and NIOSH review comments. This revision results in no change to the assigned dose and no PER is required.
**Note**: This document was canceled. There is no longer a need to keep this information in a stand-alone document. The information contained in this Technical Basis Document has been incorporated into the Idaho National Laboratory and Argonne National Laboratory-West –Occupational External Dose Technical Basis Document (ORAUT-TKBS-0007-6 Rev 03).
Approved September 30, 2004 [881 KB (45 pages)]
							
					
							Last Reviewed:  June 30, 2022						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeRadiation Dose ReconstructionAbout DCASThe Act/EEOICPADose Reconstruction (DR)plus iconDataplus iconSourcesFormats & TypesSensitive DataWork History                            Phone CallData Search and Capture EffortsMethodsProductionTechnical Documents Used in Dose ReconstructionsProgram Evaluation Reports and PlansQuality Assurance and Quality ControlSupport ContractorSoftware (IMBA)RECA ClaimsProbability of Causationplus iconCalculating PCNews & UpdatesNIOSH-IREP SoftwareSpecial Exposure Cohortplus iconSubmit a PetitionCheck Petition Statusplus iconSEC Status TableGet HelpResidual ContaminationAdvisory Boardplus iconPublic MeetingsSubcommittee and Work GroupsSEC Petition RecommendationsTechnical Support for the Review of NIOSH Dose Reconstruction ProgramReports from the Advisory Board's Technical Support ContractorTechnical Review Summaries from the Technical Support ContractorProceduresCorrespondenceWork Site InformationPublications & ProductsProgram ReviewsReports to CongressPolicies, Procedures, and GuidelinesNIOSH Public DocketRelated Program LinksContact UsHELPplus iconHelp A – ZAccessibilityAcronymsFrequently Asked Questions (FAQs)plus iconThe ActCase ConcernsClaimant CorrespondenceConflict or BiasDose ReconstructionFreedom of Information Act (FOIA)National Defense Authorization ActNIOSH-IREPProbability of CausationResidual Contamination ReportResponsibilities under Subtitle B of EEOICPA (The Act)Special Exposure CohortTechnical DocumentsWork History Phone CallGlossary Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue